glp-1 approved for pediatrics FDA Approves First Generic Liraglutide Weight Loss GLP-1 receptor agonists and obesity
Description
Also known as GLP-1 medications, these popular drugs were initially approved to treat type 2 diabetes, but doctors quickly discovered that they also facilitated significant weight loss thus, the birth of the weight-loss drug craze

GLP-1 medications have a half-life of roughly seven days for semaglutide and five days for tirzepatide

Allow them to dry completely

doi: 10.1007/s13300-017-0255-6 38 WangWHuangFHanC
doi: 10.3389/fendo.2023.1085799 5 AnsariHUHQaziSUSajidFAltafZGhazanfarSNaveedNet al
The best treatment is always the most personalized one